世界の義肢市場

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2021年08月

世界の義肢市場：製品（膝、腰、肩、肘、指/手、足首/足）、膝（一次、部分的、修正膝置換、腫瘍、カスタムメイド）、ヒップ（一次、部分的、改訂）股関節置換、腫瘍、カスタムメイド）、肩（一次、修正肩置換、腫瘍、カスタムメイド）、肘（総肘、ラジアルヘッド置換、腫瘍、カスタムメイド）、指/手（手首全体、PIP指） 、MCPフィンガープロテーゼ）、足首/足（足首全体、親指のインプラント）、地域（北米、南米、ヨーロッパ、アジア太平洋、中東、アフリカ）- 2027年までの予測

Global Endoprosthesis Market: Information By Product (Knee, Hip, Shoulder, Elbow, Finger/Hand, Ankle/Foot), By Knee (Primary, Partial, Revision Knee Replacement, Tumor, Custom Made), By Hip (Primary, Partial, Revision Hip Replacement, Tumor, Custom Made), By Shoulder (Primary, Revision Shoulder Replacement, Tumor, Custom Made),By Elbow (Total Elbow, Radial Head Replacement, Tumor, Custom Made), By Finger/Hand (Total Wrist, PIP Finger, MCP Finger Prosthesis), By Ankle/Foot (Total Ankle Great Toe Implant), and Region (North America, South America, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

レポート目次　　見積ご依頼・お問合せ　　ご購入案内

Global Endoprosthesis Market—Forecast till 2027

Endoprosthesis Market Overview

The global endoprosthesis market is anticipated to witness a healthy CAGR of 11.50% during the review period. Endoprosthesis is a treatment that includes utilizing an embed to supplant a joint in the body that has lost working capacities because of harm or disease. Degenerative joint sickness, cracks, and malignancies are for the most part normal signs that an endoprosthesis ought to be utilized.
The global endoprosthesis market accounted for USD 20,679.25 million in 2020 and is estimated to surpass USD 45,134.19 million by 2027. The expansion of the global endoprosthesis market is attributed to the elements like the expanding pervasiveness of osteoarthritis among the geriatric populace, mechanical headways in endoprosthesis gadgets empowering successful treatment, and expanding mindfulness among the populace. Besides, unfavourable impacts and significant expenses related to endoprosthesis and lack of healthcare infrastructure and unaffordability in emerging countries are set to limit the endoprosthesis market development in the future.
Market Segmentation
The global endoprosthesis market based on products has been classified as knee, Hip, Shoulder, Elbow, Finger or Hand, and Ancle or foot.
Based on product segment, the global market is segmented into the knee, hip, shoulder, elbow, finger/hand, and ankle/foot. The knee segment is further classified into primary knee replacement, partial knee replacement, custom-made replacements, revision knee replacement, and tumor.
By hip segment, the global endoprosthesis market is segmented into primary hip replacement, partial hip replacement, revision hip replacement, tumor, and custom-made partial pelvic replacements. Based on the shoulder, the global endoprosthesis market is dispersed into primary shoulder replacement, revision shoulder replacements, tumor, and custom-made replacements. In terms of the elbow, the global endoprosthesis market is segregated into total elbow replacement, radial head replacement, tumor, and custom-made replacements.
By finger/hand, the global endoprosthesis market is classified into total wrist prosthesis, (Proximal Interphalangeal) PIP finger prosthesis, and Metacarpophalangeal (MCP) finger prosthesis. In terms of ankle/foot, the global endoprosthesis market is divided into total ankle implant and great toe implant.

Regional Analysis
North America held the largest market share in 2020. In North America, the endoprosthesis market is driven by the expanding reception of in fact progressed medical care items in the region and rising joint inflammation cases. As indicated by the information distributed in the Centers for Disease Control and Prevention (CDC), the extended commonness of US grown-ups who are relied upon to report specialist analyzed joint pain is 67 million of every 2020, and by 2030, the number is projected to arrive at 72 million. Accordingly, the district will request a compelling endoprosthesis gadget to conquer this sickness trouble. This factor is additionally projected to drive market development.
South America has seen extensive development in the endoprosthesis market and held a portion of the overall industry of 14.6% in 2020. Across South America, endoprosthesis rehearses are completed in various clinical offices, for example, government-controlled research facilities. Monetarily autonomous patients frequently pick private research facility treatment. Brazil is one of the significant nations involving the biggest portion of the overall industry in the South American endoprosthesis market.
Prominent Players
The Major Companies Covered in this Report are Johnson & JohnsonServices, Inc.(US), Zimmer Biomet HoldingsInc.(US), Stryker(US), Smith & Nephew (UK), CorinLtd(UK), MedactaInternational SA(Switzerland), Exactech, Inc.(US), MicroPortOrthopedics,Inc.(US), A. (Switzerland), BraunMelsungenAG (Germany), Total Ankle Replacement (STAR; Small Bone Innovations, Morrisville, US), INBONE (Wright Medical Technology, Arlington, US), Agility (DePuy, Warsaw, US), and Salto Talaris (Tornier, Montbonnot, France).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF OSTEOARTHRITIS AMONG THE GERIATRIC POPULATION

4.2.2 INCREASED INCIDENCES OF BONE FRACTURES

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN ENDOPROSTHESIS DEVICES ENABLING EFFECTIVE TREATMENT

4.2.4 GROWING AWARENESS AMONG POPULATION

4.3 RESTRAINTS

4.3.1 ADVERSE EFFECTS ASSOCIATED WITH ENDOPROSTHESIS POST SURGERY

4.3.2 LACK OF HEALTHCARE INFRASTRUCTURE AND UNAFFORDABILITY IN EMERGING COUNTRIES

4.3.3 RESTRAINT IMPACT ANALYSIS

4.4 OPPORTUNITIES

4.4.1 RISING R&D INVESTMENTS FOR ENDOPROSTHESIS

4.4.2 INCREASING NUMBER OF PRODUCT LAUNCH, MERGER & ACQUISITION, AND EXPANSION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE ENDOPROSTHESIS MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON MARKET

5.3.4 DEMAND-SUPPLY GAP ANALYSIS

6 GLOBAL ENDOPROSTHESIS MARKET BY PRODUCT

6.1 OVERVIEW

6.2 KNEE

6.3 HIP

6.4 SHOULDER

6.5 ELBOW

6.6 FINGER/HAND

6.7 ANKLE/FOOT

7 GLOBAL ENDOPROSTHESIS MARKET BY KNEE

7.1 OVERVIEW

7.2 PRIMARY KNEE REPLACEMENT

7.2.1 PRIMARY CEMENTED KNEE REPLACEMENT

7.2.2 PRIMARY CEMENTLESS KNEE REPLACEMENT

7.2.3 PRIMARY HYBRID KNEE REPLACEMENT

7.2.4 BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT

7.2.4.1 PATELLA RESURFACING

7.2.4.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.2.4.3 UNCOATED KNEE REPLACEMENT

7.2.4.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.2.5 MOBILE-BEARING

7.2.6 FIXED-BEARING

7.2.6.1 FIXED-BEARING WITH CEMENTED STEM

7.2.6.2 OTHERS

7.2.7 POSTERIOR STABILIZED

7.2.8 CRUCIATE-RETAINING

7.2.8.1 ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING

7.2.8.2 LATERAL PIVOT

7.2.8.3 MEDIAL PIVOT

7.3 PARTIAL KNEE REPLACEMENT

7.3.1 UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT

7.3.2 BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT

7.3.3 PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT

7.3.3.1 PATELLA RESURFACING

7.3.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.3.3.3 UNCOATED KNEE REPLACEMENT

7.3.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.4 REVISION KNEE REPLACEMENT

7.4.1 COMPLETE NON-HINGED REVISION KNEE REPLACEMENT

7.4.2 COMPLETE HINGED REVISION KNEE REPLACEMENT

7.4.3 PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT

7.4.3.1 PATELLA RESURFACING

7.4.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT

7.4.3.3 UNCOATED KNEE REPLACEMENT

7.4.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)

7.4.3.5 DEFECT FILLER (METAPHYSEAL)

7.5 TUMOR

7.5.1 PROXIMAL TIBIA REPLACEMENT

7.5.2 DISTAL FEMUR REPLACEMENT

7.6 CUSTOM MADE REPLACEMENT

7.6.1 GROWING PROSTHESIS

8 GLOBAL ENDOPROSTHESIS MARKET BY HIP

8.1 OVERVIEW

8.2 PRIMARY HIP REPLACEMENT

8.2.1 PRIMARY CEMENTED HIP REPLACEMENT

8.2.2 PRIMARY CEMENTLESS HIP REPLACEMENT

8.2.3 PRIMARY HYBRID HIP REPLACEMENT

8.2.3.1 DUAL MOBILITY CUP CEMENTED

8.2.3.2 DUAL MOBILITY CUP CEMENTLESS

8.2.4 HIP RESURFACING

8.2.5 TOTAL HIP RESURFACING

8.2.6 HEMI HIP RESURFACING

8.3 PARTIAL HIP REPLACEMENT

8.3.1 BIPOLAR PARTIAL HIP REPLACEMENT

8.3.2 UNIPOLAR PARTIAL HIP REPLACEMENT

8.3.3 ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT

8.4 CUSTOM HIP REPLACEMENTS

8.5 REVISION HIP REPLACEMENT

8.5.1 COMPLETE HIP REVISION

8.5.1.1 COMPLETE HIP REVISION WITH DUAL MOBILITY CUP

8.5.2 ACETABULAR COMPONENT REVISION

8.5.2.1 ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP

8.5.3 FEMORAL STEM REVISION

8.5.4 OTHER HIP REVISION

8.6 TUMOR

8.6.1 PROXIMAL FEMUR REPLACEMENT

9 GLOBAL ENDOPROSTHESIS MARKET BY SHOULDER

9.1 OVERVIEW

9.2 PRIMARY SHOULDER REPLACEMENT

9.2.1 PARTIAL SHOULDER REPLACEMENT

9.2.2 TOTAL/PRIMARY SHOULDER REPLACEMENT

9.2.3 REVERSE SHOULDER REPLACEMENT

9.2.4 SHOULDER RESURFACING

9.3 REVISION SHOULDER REPLACEMENTS

9.4 TUMOR

9.4.1 PROXIMAL HUMERUS REPLACEMENT

9.5 CUSTOM MADE REPLACEMENTS

10 GLOBAL ENDOPROSTHESIS MARKET BY ELBOW

10.1 OVERVIEW

10.2 TOTAL ELBOW REPLACEMENT

10.3 RADIAL HEAD REPLACEMENT

10.4 TUMOR

10.4.1 PROXIMAL ULNA REPLACEMENT

10.4.2 DISTAL HUMERUS REPLACEMENT

10.5 CUSTOM MADE REPLACEMENTS

11 GLOBAL ENDOPROSTHESIS MARKET BY FINGER/HAND

11.1 OVERVIEW

11.2 TOTAL WRIST PROTHESIS

11.3 PIP FINGER PROSTHESIS

11.4 MCP FINGER PROSTHESIS

11.4.1 CARPOMETACARPAL JOINT PROSTHESIS

11.4.2 OTHERS

12 GLOBAL ENDOPROSTHESIS MARKET BY ANKLE/FOOT

12.1 OVERVIEW

12.2 TOTAL ANKLE

12.3 GREAT TOE IMPLANT

13 GLOBAL ENDOPROSTHESIS MARKET, BY REGION

13.1 OVERVIEW

13.2 NORTH AMERICA

13.2.1 US

13.2.2 CANADA

13.2.3 MEXICO

13.3 SOUTH AMERICA

13.3.1 ARGENTINA

13.3.2 BRAZIL

13.3.3 COLOMBIA

13.3.4 PERU

13.3.5 CHILE

13.3.6 ECUADOR

13.3.7 REST OF SOUTH AMERICA

13.4 EUROPE

13.4.1 GERMANY

13.4.2 AUSTRIA

13.4.3 SWISS

13.4.4 FINLAND

13.4.5 DENMARK

13.4.6 NORWAY

13.4.7 SWEDEN

13.4.8 BELGIUM

13.4.9 FRANCE

13.4.10 NETHERLANDS

13.4.11 GREAT BRITAIN

13.4.12 CZECHIA

13.4.13 ITALIA

13.4.14 SPAIN

13.4.15 HUNGARY

13.4.16 IRELAND

13.4.17 PORTUGAL

13.4.18 POLAND

13.4.19 RUSSIA

13.4.20 ROMANIA

13.4.21 TURKEY

13.4.22 REST OF EUROPE

13.5 ASIA-PACIFIC

13.5.1 CHINA

13.5.2 JAPAN

13.5.3 INDIA

13.5.4 AUSTRALIA

13.5.5 SOUTH KOREA

13.5.6 TAIWAN

13.5.7 NEW ZEALAND

13.5.8 REST OF ASIA-PACIFIC

13.6 MIDDLE EAST & AFRICA

13.6.1 SAUDI ARABIA

13.6.2 UAE

13.6.3 EGYPT

13.6.4 ISRAEL

13.6.5 SOUTH AFRICA

13.6.6 SYRIA

13.6.7 REST OF MEA

14 COMPETITIVE LANDSCAPE

14.1 COMPETITIVEOVERVIEW

14.2 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

14.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ENDOPROSTHESIS MARKET

14.4 COMPETITIVE BENCHMARKING

14.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ENDOPROSTHESIS MARKET

14.6 KEY DEVELOPMENT ANALYSIS

14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

14.7.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

14.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES

14.8 MAJOR PLAYERS FINANCIAL MATRIX

14.8.1 REVENUE OF MAJOR PLAYERS

14.8.2 R&D EXPENDITURE

15 COMPANY PROFILES

15.1 JOHNSON & JOHNSON SERVICES, INC.

15.1.1 COMPANY OVERVIEW

15.1.2 FINANCIAL OVERVIEW

15.1.3 PRODUCTS/SERVICES OFFERED

15.1.4 KEY DEVELOPMENTS

15.1.5 SWOT ANALYSIS

15.1.6 KEY STRATEGIES

15.2 ZIMMER BIOMET HOLDINGS INC.

15.2.1 COMPANY OVERVIEWS

15.2.2 FINANCIAL OVERVIEW

15.2.3 PRODUCTS/SERVICES OFFERED

15.2.4 KEY DEVELOPMENTS

15.2.5 SWOT ANALYSIS

15.2.6 KEY STRATEGIES

15.3 STRYKER

15.3.1 COMPANY OVERVIEW

15.3.2 FINANCIAL OVERVIEW

15.3.3 PRODUCTS/SERVICES OFFERED

15.3.4 KEY DEVELOPMENTS

15.3.5 SWOT ANALYSIS

15.3.6 KEY STRATEGIES

15.4 SMITH AND NEPHEW

15.4.1 COMPANY OVERVIEW

15.4.2 FINANCIAL OVERVIEW

15.4.3 PRODUCTS/SERVICES OFFERED

15.4.4 KEY DEVELOPMENTS

15.4.5 SWOT ANALYSIS

15.4.6 KEY STRATEGIES

15.5 WALDEMAR LINK GMBH & CO. KG

15.5.1 COMPANY OVERVIEW

15.5.2 FINANCIAL OVERVIEW

15.5.3 PRODUCTS/SERVICES OFFERED

15.5.4 KEY DEVELOPMENTS

15.5.5 SWOT ANALYSIS

15.5.6 KEY STRATEGIES

15.6 LIMACORPORATE SPA.

15.6.1 COMPANY OVERVIEW

15.6.2 FINANCIAL OVERVIEW

15.6.3 PRODUCTS/SERVICES OFFERED

15.6.4 KEY DEVELOPMENTS

15.6.5 SWOT ANALYSIS

15.6.6 KEY STRATEGIES

15.7 CORIN LTD

15.7.1 COMPANY OVERVIEW

15.7.2 FINANCIAL OVERVIEW

15.7.3 PRODUCTS OFFERED

15.7.4 KEY DEVELOPMENTS

15.7.5 SWOT ANALYSIS

15.7.6 KEY STRATEGIES

15.8 PETER BREHM GMBH

15.8.1 COMPANY OVERVIEW

15.8.2 FINANCIAL OVERVIEW

15.8.3 PRODUCTS OFFERED

15.8.4 KEY DEVELOPMENTS

15.8.5 SWOT ANALYSIS

15.8.6 KEY STRATEGIES

15.9 MATHYS LTD BETTLACH

15.9.1 COMPANY OVERVIEW

15.9.2 FINANCIAL OVERVIEW

15.9.3 PRODUCTS OFFERED

15.9.4 KEY DEVELOPMENTS

15.9.5 SWOT ANALYSIS

15.9.6 KEY STRATEGIES

15.10 B. BRAUN MELSUNGEN AG

15.10.1 COMPANY OVERVIEW

15.10.2 FINANCIAL OVERVIEW

15.10.3 PRODUCTS OFFERED

15.10.4 KEY DEVELOPMENTS

15.10.5 SWOT ANALYSIS

15.10.6 KEY STRATEGIES

15.11 MEDACTA INTERNATIONAL SA

15.11.1 COMPANY OVERVIEW

15.11.2 FINANCIAL OVERVIEW

15.11.3 PRODUCTS/SERVICES OFFERED

15.11.4 KEY DEVELOPMENTS

15.11.5 SWOT ANALYSIS

15.11.6 KEY STRATEGIES

15.12 EXACTECH, INC.

15.12.1 COMPANY OVERVIEW

15.12.2 FINANCIAL OVERVIEW

15.12.3 PRODUCTS OFFERED

15.12.4 KEY DEVELOPMENTS

15.12.5 SWOT ANALYSIS

15.12.6 KEY STRATEGIES

15.13 MICROPORT ORTHOPEDICS, INC.

15.13.1 COMPANY OVERVIEW

15.13.2 FINANCIAL OVERVIEW

15.13.3 PRODUCTS OFFERED

15.13.4 KEY DEVELOPMENTS

15.13.5 SWOT ANALYSIS

15.13.6 KEY STRATEGIES

15.14 TIPSAN

15.14.1 COMPANY OVERVIEW

15.14.2 FINANCIAL OVERVIEW

15.14.3 PRODUCTS OFFERED

15.14.4 KEY DEVELOPMENTS

15.14.5 SWOT ANALYSIS

15.14.6 KEY STRATEGIES

15.15 BAUMER SA.

15.15.1 COMPANY OVERVIEW

15.15.2 FINANCIAL OVERVIEW

15.15.3 PRODUCTS OFFERED

15.15.4 KEY DEVELOPMENTS

15.15.5 SWOT ANALYSIS

15.15.6 KEY STRATEGIES

15.16 IMPOL

15.16.1 COMPANY OVERVIEW

15.16.2 FINANCIAL OVERVIEW

15.16.3 PRODUCTS OFFERED

15.16.4 KEY DEVELOPMENTS

15.16.5 SWOT ANALYSIS

15.16.6 KEY STRATEGIES

15.17 GROUPE LEPINE

15.17.1 COMPANY OVERVIEW

15.17.2 FINANCIAL OVERVIEW

15.17.3 PRODUCTS OFFERED

15.17.4 KEY DEVELOPMENTS

15.17.5 SWOT ANALYSIS

15.17.6 KEY STRATEGIES

15.18 CONFORMIS

15.18.1 COMPANY OVERVIEW

15.18.2 FINANCIAL OVERVIEW

15.18.3 PRODUCTS OFFERED

15.18.4 KEY DEVELOPMENTS

15.18.5 SWOT ANALYSIS

15.18.6 KEY STRATEGIES

15.19 DJO

15.19.1 COMPANY OVERVIEW

15.19.2 FINANCIAL OVERVIEW

15.19.3 PRODUCTS OFFERED

15.19.4 KEY DEVELOPMENTS

15.19.5 SWOT ANALYSIS

15.19.6 KEY STRATEGIES

15.20 IMPLANTCAST

15.20.1 COMPANY OVERVIEW

15.20.2 FINANCIAL OVERVIEW

15.20.3 PRODUCTS OFFERED

15.20.4 KEY DEVELOPMENTS

15.20.5 SWOT ANALYSIS

15.20.6 KEY STRATEGIES

16 APPENDIX

16.1 REFERENCES

16.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 4 GLOBAL: ENDOPROSTHESIS MARKET, BY KNEE, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: ENDOPROSTHESIS MARKET, BY HIP, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: ENDOPROSTHESIS MARKET, BY ELBOW, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: ENDOPROSTHESIS MARKET, BY KNEE TYPE, 2018-2027 (USD MILLION)

TABLE 11 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY TYPE 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTED KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTLESS KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL: ENDOPROSTHESIS MARKET, FOR MOBILE-BEARING, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY REGION, 2018–2027 (USD MILLION)

TABLE 24 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2018–2027 (USD MILLION)

TABLE 25 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING WITH CEMENTED STEM, BY REGION, 2018–2027 (USD MILLION)

TABLE 26 GLOBAL: ENDOPROSTHESIS MARKET, BY OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 27 GLOBAL: ENDOPROSTHESIS MARKET, FOR POSTERIOR STABILIZED, BY REGION, 2018–2027 (USD MILLION)

TABLE 28 GLOBAL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY REGION, 2018–2027 (USD MILLION)

TABLE 29 GLOBAL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018–2027 (USD MILLION)

TABLE 30 GLOBAL: ENDOPROSTHESIS MARKET, FOR ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING, BY REGION, 2018–2027 (USD MILLION)

TABLE 31 GLOBAL: ENDOPROSTHESIS MARKET, FOR LATERAL PIVOT, BY REGION, 2018–2027 (USD MILLION)

TABLE 32 GLOBAL: ENDOPROSTHESIS MARKET, FOR MEDIALPIVOT, BY REGION, 2018–2027 (USD MILLION)

TABLE 33 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 34 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY TYPE 2018–2027 (USD MILLION)

TABLE 35 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 36 GLOBAL: ENDOPROSTHESIS MARKET, FOR BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 37 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 38 GLOBAL: ENDOPROSTHESIS MARKET, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 39 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 40 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 41 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 42 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2018–2027 (USD MILLION)

TABLE 43 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 44 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 45 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE NON-HINGED REVISION KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 46 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HINGED REVISION KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 47 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 48 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 49 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 50 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 51 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 52 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2018–2027 (USD MILLION)

TABLE 53 GLOBAL: ENDOPROSTHESIS MARKET, FOR DEFECT FILLER (METAPHYSEAL), BY REGION, 2018–2027 (USD MILLION)

TABLE 54 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2018–2027 (USD MILLION)

TABLE 55 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2018–2027 (USD MILLION)

TABLE 56 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL TIBIA REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 57 GLOBAL: ENDOPROSTHESIS MARKET, FOR DISTAL FEMUR REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 58 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 59 GLOBAL: ENDOPROSTHESIS MARKET, FOR GROWING PROSTHESIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 60 GLOBAL: ENDOPROSTHESIS MARKET, BY HIP TYPE, 2018-2027 (USD MILLION)

TABLE 61 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 62 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 63 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTED HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 64 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTLESS HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 65 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 66 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 67 GLOBAL: ENDOPROSTHESIS MARKET, FOR DUAL MOBILITY CUP CEMENTED, BY REGION, 2018–2027 (USD MILLION)

TABLE 68 GLOBAL: ENDOPROSTHESIS MARKET, FOR DUAL MOBILITY CUP CEMENTLESS, BY REGION, 2018–2027 (USD MILLION)

TABLE 69 GLOBAL: ENDOPROSTHESIS MARKET, FOR HIP RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 70 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL HIP RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 71 GLOBAL: ENDOPROSTHESIS MARKET, FOR HEMI HIP RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 72 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 73 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 74 GLOBAL: ENDOPROSTHESIS MARKET, FOR BIPOLAR PARTIAL HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 75 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNIPOLAR PARTIAL HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 76 GLOBAL: ENDOPROSTHESIS MARKET, FOR ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 77 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM HIP REPLACEMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 78 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 79 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 80 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 81 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION WITH DUAL MOBILITY CUP, BY REGION, 2018–2027 (USD MILLION)

TABLE 82 GLOBAL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, BY REGION, 2018–2027 (USD MILLION)

TABLE 83 GLOBAL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP, BY REGION, 2018–2027 (USD MILLION)

TABLE 84 GLOBAL: ENDOPROSTHESIS MARKET, FOR FEMORAL STEM REVISION, BY REGION, 2018–2027 (USD MILLION)

TABLE 85 GLOBAL: ENDOPROSTHESIS MARKET, FOR OTHER HIP REVISION, BY REGION, 2018–2027 (USD MILLION)

TABLE 86 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2018–2027 (USD MILLION)

TABLE 87 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL FEMUR REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 88 GLOBAL: ENDOPROSTHESIS MARKET, BY SHOULDER TYPE, 2018-2027 (USD MILLION)

TABLE 89 GLOBAL: ENDOPROSTHESIS MARKET, BY PRIMARY SHOULDER REPLACEMENT, 2018–2027 (USD MILLION)

TABLE 90 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 91 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL SHOULDER REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 92 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL/PRIMARY SHOULDER REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 93 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVERSE SHOULDER REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 94 GLOBAL: ENDOPROSTHESIS MARKET, FOR SHOULDER RESURFACING, BY REGION, 2018–2027 (USD MILLION)

TABLE 95 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION SHOULDER REPLACEMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 96 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2018–2027 (USD MILLION)

TABLE 97 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2018–2027 (USD MILLION)

TABLE 98 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL HUMERUS REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 99 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 100 GLOBAL: ENDOPROSTHESIS MARKET, BY ELBOW TYPE, 2018-2027 (USD MILLION)

TABLE 101 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL ELBOW REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 102 GLOBAL: ENDOPROSTHESIS MARKET, FOR RADIAL HEAD REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 103 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2018–2027 (USD MILLION)

TABLE 104 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2018–2027 (USD MILLION)

TABLE 105 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL ULNA REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 106 GLOBAL: ENDOPROSTHESIS MARKET, FOR DISTAL HUMERUS REPLACEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 107 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 108 GLOBAL: ENDOPROSTHESIS MARKET, BY FINGER/HAND TYPE, 2018-2027 (USD MILLION)

TABLE 109 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL WRIST PROTHESIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 110 GLOBAL: ENDOPROSTHESIS MARKET, FOR PIP FINGER PROSTHESIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 111 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 112 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 113 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 114 GLOBAL: ENDOPROSTHESIS MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 115 GLOBAL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT TYPE, 2018-2027 (USD MILLION)

TABLE 116 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL ANKLE, BY REGION, 2018–2027 (USD MILLION)

TABLE 117 GLOBAL: ENDOPROSTHESIS MARKET, FOR GREAT TOE IMPLANT, BY REGION, 2018–2027 (USD MILLION)

TABLE 118 GLOBAL: ENDOPROSTHESIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 119 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 120 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 121 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRODUCT, BY KNEE, 2018-2027 (USD MILLION)

TABLE 122 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 123 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 124 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 125 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 126 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 130 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2018-2027 (USD MILLION)

TABLE 131 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY TYPE, 2018-2027 (USD MILLION)

TABLE 132 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 133 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 134 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 135 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 136 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 137 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 138 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 139 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 140 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018-2027 (USD MILLION)

TABLE 141 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 142 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 143 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 144 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 145 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 146 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 147 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 148 US: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 149 US: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 150 US: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 151 US: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 152 US: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 153 US: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 154 US: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 155 US: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 156 US: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 157 US: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 158 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 159 US: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 160 US: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 161 US: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 162 US: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 163 US: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 164 US: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 165 US: ENDOPROSTHESIS MARKET, COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 166 US: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 167 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 168 US: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018-2027 (USD MILLION)

TABLE 169 US: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 170 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 171 US: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 172 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 173 US: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 174 US: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 175 US: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 176 CANADA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 177 CANADA: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 178 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 179 CANADA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 180 CANADA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 181 CANADA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 182 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 183 CANADA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 184 CANADA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 185 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 186 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 187 CANADA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 188 CANADA: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 189 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 190 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 191 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 192 CANADA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 193 CANADA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 194 CANADA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 195 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 196 CANADA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018-2027 (USD MILLION)

TABLE 197 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 198 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 199 CANADA: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 200 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 201 CANADA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 202 CANADA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 203 CANADA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 204 MEXICO: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 205 MEXICO: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 206 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 207 MEXICO: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 208 MEXICO: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 209 MEXICO: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 210 MEXICO: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 211 MEXICO: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 212 MEXICO: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 213 MEXICO: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT 2018-2027 (USD MILLION)

TABLE 214 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 215 MEXICO: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 216 MEXICO: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 217 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 218 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 219 MEXICO: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 220 MEXICO: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 221 MEXICO: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 222 MEXICO: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 223 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 224 MEXICO: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018-2027 (USD MILLION)

TABLE 225 MEXICO: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 226 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 227 MEXICO: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 228 MEXICO: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 229 MEXICO: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 230 MEXICO: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 231 MEXICO: ENDOPROSTHESIS MARKET, FOR ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 232 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 233 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 234 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 235 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 236 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 237 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 238 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 239 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 240 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 241 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 242 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 243 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 244 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 245 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 246 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 247 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 248 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 249 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 250 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 251 SOUTH AMERICA: ENDOPROSTHESIS MARKET, ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 252 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 253 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018-2027 (USD MILLION)

TABLE 254 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 255 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 256 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 257 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 258 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 259 SOUTH AMERICA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 260 SOUTH AMERICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 261 ARGENTINA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 262 ARGENTINA: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 263 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 264 ARGENTINA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 265 ARGENTINA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 266 ARGENTINA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 267 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 268 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 269 ARGENTINA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 270 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 271 ARGENTINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 272 ARGENTINA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 273 ARGENTINA: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 274 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 275 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 276 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 277 ARGENTINA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 278 ARGENTINA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 279 ARGENTINA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 280 ARGENTINA: ENDOPROSTHESIS MARKET, TUMOR, 2018-2027 (USD MILLION)

TABLE 281 ARGENTINA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2018-2027 (USD MILLION)

TABLE 282 ARGENTINA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 283 ARGENTINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 284 ARGENTINA: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 285 ARGENTINA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 286 ARGENTINA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 287 ARGENTINA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 288 ARGENTINA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 289 BRAZIL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 290 BRAZIL: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 291 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 292 BRAZIL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 293 BRAZIL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 294 BRAZIL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 295 BRAZIL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 296 BRAZIL: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 297 BRAZIL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 298 BRAZIL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 299 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 300 BRAZIL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 301 BRAZIL: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 302 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 303 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 304 BRAZIL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 305 BRAZIL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 306 BRAZIL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2018-2027 (USD MILLION)

TABLE 307 BRAZIL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2018-2027 (USD MILLION)

TABLE 308 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 309 BRAZIL: ENDOPROSTHESIS MARKET, FOR SHOULDER, 2018-2027 (USD MILLION)

TABLE 310 BRAZIL: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 311 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 312 BRAZIL: ENDOPROSTHESIS MARKET, BY ELBOW, 2018-2027 (USD MILLION)

TABLE 313 BRAZIL: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 314 BRAZIL: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2018-2027 (USD MILLION)

TABLE 315 BRAZIL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2018-2027 (USD MILLION)

TABLE 316 BRAZIL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2018-2027 (USD MILLION)

TABLE 317 COLOMBIA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 318 COLOMBIA: ENDOPROSTHESIS MARKET, BY KNEE, 2018-2027 (USD MILLION)

TABLE 319 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 320 COLOMBIA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 321 COLOMBIA: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 322 COLOMBIA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2018-2027 (USD MILLION)

TABLE 323 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 324 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 325 COLOMBIA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 326 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 327 COLOMBIA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2018-2027 (USD MILLION)

TABLE 328 COLOMBIA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2018-2027 (USD MILLION)

TABLE 329 COLOMBIA: ENDOPROSTHESIS MARKET, BY HIP, 2018-2027 (USD MILLION)

TABLE 330 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 331 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2018-2027 (USD MILLION)

TABLE 332 COLOMBIA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2018-2027 (USD MILLION)

TABLE 333 COLOMBIA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2018-2027 (USD MILLION)
LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 ENDOPROSTHESIS MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ENDOPROSTHESIS MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 VALUE CHAIN ANALYSIS: ENDOPROSTHESIS MARKET

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: ENDOPROSTHESIS MARKET

FIGURE 8 GLOBAL ENDOPROSTHESIS MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION)

FIGURE 9 GLOBAL ENDOPROSTHESIS MARKET, BY KNEE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL ENDOPROSTHESIS MARKET, BY HIP, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL ENDOPROSTHESIS MARKET, BY SHOULDER TYPE, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL ENDOPROSTHESIS MARKET, BY ELBOW TYPE, 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL ENDOPROSTHESIS MARKET, BY FINGER/HAND TYPE, 2020 & 2027 (USD MILLION)

FIGURE 14 GLOBAL ENDOPROSTHESIS MARKET, BY ANKLE/FOOT TYPE, 2020 & 2027 (USD MILLION)

FIGURE 15 GLOBAL: ENDOPROSTHESIS MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 16 GLOBAL: ENDOPROSTHESIS MARKET SHARE, BY REGION 2020 (%)

FIGURE 17 NORTH AMERICA: ENDOPROSTHESIS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 18 SOUTH AMERICA ENDOPROSTHESIS MARKET, BY REGION, 2020 (%)

FIGURE 19 EUROPE: ENDOPROSTHESIS MARKET, BY COUNTRY, 2020 (%)

FIGURE 20 ASIA-PACIFIC ENDOPROSTHESIS MARKET, BY REGION, 2020 (%)

FIGURE 21 MIDDLE EAST & AFRICA: ENDOPROSTHESIS MARKET SHARE, BY REGION 2020 (%)

FIGURE 22 THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 24 GLOBAL ENDOPROSTHESIS MARKET: COMPETITIVE LANDSCAPE

FIGURE 25 REVENUE OF MAJOR PLAYERS, 2020

FIGURE 26 MAJOR PLAYERS R&D EXPENDITURE, 2020

FIGURE 27 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ZIMMER BIOMET HOLDINGS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ZIMMER BIOMET HOLDINGS INC.: SWOT ANALYSIS

FIGURE 31 STRYKER: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 STRYKER: SWOT ANALYSIS

FIGURE 33 SMITH AND NEPHEW: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 SMITH AND NEPHEW: SWOT ANALYSIS

FIGURE 35 WALDEMAR LINK GMBH & CO. KG: SWOT ANALYSIS

FIGURE 36 LIMACORPORATE SPA: SWOT ANALYSIS

FIGURE 37 CORIN LTD: SWOT ANALYSIS

FIGURE 38 PETER BREHM GMBH: SWOT ANALYSIS

FIGURE 39 MATHYS LTD BETTLACH: SWOT ANALYSIS

FIGURE 40 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS

FIGURE 42 MEDACTA INTERNATIONAL SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 43 MEDACTA INTERNATIONAL SA: SWOT ANALYSIS

FIGURE 44 EXACTECH, INC.: SWOT ANALYSIS

FIGURE 45 MICROPORT ORTHOPEDICS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 46 MICROPORT ORTHOPEDICS, INC.: SWOT ANALYSIS

FIGURE 47 TIPSAN: SWOT ANALYSIS

FIGURE 48 BAUMER S.A.: SWOT ANALYSIS

FIGURE 49 IMPOL: SWOT ANALYSIS

FIGURE 50 GROUPE LEPINE: SWOT ANALYSIS

FIGURE 51 CONFORMIS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 52 CONFORMIS: SWOT ANALYSIS

FIGURE 53 DJO: SWOT ANALYSIS

FIGURE 54 IMPLANTCAST: SWOT ANALYSIS